Earnings Feed
Start Free
|4/AJan 23, 6:40 PM ET

Endicott David J. 4/A

4/A · ALLERGAN INC · Filed Jan 23, 2013

Insider Transaction Report

Form 4/AAmended
Period: 2012-11-29
ALLERGAN INCAGN
Endicott David J.
CVP and President, AGN Med US
Transactions
  • Exercise/Conversion

    Common Stock

    2012-11-29$64.47/sh+100$6,447→ 20,452 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2012-11-29−100→ 1,840 total
    Exercise: $64.47Exp: 2018-02-14→ Common Stock (100 underlying)
  • Exercise/Conversion

    Common Stock

    2012-11-29$64.47/sh+1,840$118,625→ 22,292 total
  • Sale

    Common Stock

    2012-11-29$92.27/sh−100$9,227→ 22,192 total
  • Sale

    Common Stock

    2012-11-29$92.33/sh−1,840$169,888→ 20,352 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2012-11-29−1,840→ 0 total
    Exercise: $64.47Exp: 2018-02-14→ Common Stock (1,840 underlying)
Holdings

  • Common Stock

    (indirect: By Trust)
    0

  • Common Stock

    (indirect: By Trust)
    3,111.907
Footnotes (3)
  • [F1]Shares allocated to reporting person's SIP account as of reporting date.
  • [F2]Shares allocated to the reporting person's ESOP account as of reporting date.
  • [F3]The option became exercisable in four equal annual installments beginning February 14, 2009.

Documents

1 file
  • 4
    form4a.xml

    PRIMARY DOCUMENT